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Abstract
Background: Frailty is a clinical condition among older adults defined as the loss of resources in one or more
domains (i.e., physical, psychological and social domains) of individual functioning. In frail subjects emergency
situations and mobility levels need to be carefully monitored. This study aimed to: i) evaluate differences in the
mobility index (MI) provided by ADAMO system, an innovative remote monitoring device for older adults; ii)
compare the association of the MI and a traditional physical measure with frailty.
Methods: Twenty-five community-dwelling older adults (71 ± 6 years; 60% women) wore ADAMO continuously for
a week. The time percentage spent in Low, Moderate and Vigorous Activities was assessed using ADAMO system.
Walking ability and frailty were measured using the 400 m walk test and the Tilburg Frailty Indicator, respectively.
Results: Controlling for age and gender, the ANCOVA showed that frail and robust participants were different for
Low (frail = 58.8%, robust = 42.0%, p < 0.001), Moderate (frail = 25.5%, robust = 33.8%, p = 0.008), and Vigorous
Activity (frail = 15.7%, robust = 24.2%, p = 0.035). Using cluster analysis, participants were divided into two groups,
one with higher and one with lower mobility. Controlling for age and gender, linear regression showed that the MI
clusters were associated with total (β = 0.571, p = 0.002), physical (β = 0.381, p = 0.031) and social (β = 0.652, p < 0.
001) frailty; and the 400 m walk test was just associated with total (β = 0.404, p = 0.043) and physical frailty (β = 0.
668, p = 0.002).
Conclusion: ADAMO system seems to be a suitable time tracking that allows to measure mobility levels in a non-
intrusive way providing wider information on individual health status and specifically on frailty. For the frail
individuals with an important loss of resources in physical domain, this innovative device may represent a
considerable help in preventing physical consequences and in monitoring functional status.
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Background
Population ageing is transforming the demographic struc-
ture in Europe [1] and in the World [2] and this change is
recognized as one of the most significant public challenges
in term of health care and social problems [3]. Thus, pre-
ventive and health promotion strategies have been pursued
in order to encourage both a healthy ageing and an inde-
pendent living.
Information and communication technologies (ICTs)
may be an innovative and pervasive tool to monitor and
evaluate health domains in older adults during everyday
life activity [4, 5]. For example, telemonitoring (i.e., the
use of audio, video and other telecommunication tech-
nologies to monitor health status at distance) may re-
duce the possible negative outcomes, such as emergency
visits or hospitalisations [6]. The use of ICTs seems to
improve also the quality of life, the social interaction
and the general wellbeing of older adults [7, 8].
* Correspondence: alberto.rainoldi@unito.it
†Anna Mulasso and Paolo Riccardo Brustio contributed equally to this work.
1NeuroMuscular Function Research Group, School of Exercise and Sport
Sciences, Department of Medical Sciences, University of Torino, Torino, Italy
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Mulasso et al. BMC Geriatrics           (2019) 19:88 
https://doi.org/10.1186/s12877-019-1089-z
ADAMO system (Caretek S.r.l., Turin, Italy) is an innova-
tive remote monitoring device for older adults. Briefly,
ADAMO system is composed of a Base Station, installed at
user’s home, receiving data from a carewatch worn by the
same user. Wearing the carewatch during every daily life ac-
tivities, ADAMO system is able to monitor user’s indoor and
outdoor activity, by signalling any suspicious immobility, any
falls followed by lack of movement and mobility index (MI)
levels. Specifically, the carewatch records raw data from its
sensors (i.e., triaxial accelerometer sampling at 50Hz) and,
every 10min, transmits them to the Base Station, which for-
wards such an information to the storage server. ADAMO
system was specifically designed for older adults and demon-
strated to measure the number of steps in walking activity
accurately, in particular for slow walking speed [9], typical of
older adults and specific populations, such as frail older
adults [10].
Frailty is a clinical condition among older adults defined as
the loss of resource in one or more domains (i.e., physical,
psychological and social domains) of individual functioning
[11]. Senile anorexia and malnutrition have to be considered
among the main risk factors for frailty. Authors [12, 13]
underline that the risk of frailty may be reduced by improved
nutritional status for macronutrients and micronutrients.
Frailty makes older adults more vulnerable and susceptible
to adverse health outcomes, such as falls, hospitalization,
institutionalization and mortality [14]. An impaired physical
function is the major indicator of frailty [14] and negatively
affects the autonomy in the activities of daily living. In par-
ticular, the mobility function, defined as the ability to move
in the environment easily and without restriction [15], re-
sulted strictly related to frailty [14]. Indeed, poor mobility
was associated with higher frailty scores [16]. Moreover, the
daily step count and the amount of energy spent performing
the activities of daily living (in kcal/week) were strongly asso-
ciated with frailty levels [17].
Generally, mobility function, based on self-report or
performance-based measurements, are useful tools for
frailty screening (e.g., [16, 18–21]). However, these mea-
sures may lead to possible self-report bias, non-objective
parameters [22] or may be not ecological. For example, a
Walking test, that evaluates the time taken to walk a
path, typically is used to assess mobility function in older
adults (e.g., [23, 24]). However, this assessment is lim-
ited to laboratory environment and does not reflect
the mobility in everyday life activity. Thus, ICT sys-
tems may provide objective parameters for monitoring
continuously and in a non-intrusive way the older
adults during everyday life. Indeed, ICT systems that
evaluates mobility levels (e.g., resting, sitting or walk-
ing activity) during everyday life activity may over-
come the limitations of the traditional assessment of
older adults’ health status and provide specific infor-
mation on their behaviour [25, 26].
Methods
Study aims
To the best of our knowledge no study compared physical
screening tools and an ICT system aimed to measure the
mobility level for evaluating frailty in older adults. Therefore,
the purpose of this study was to investigate the relationships
between the mobility index (MI) provided by ADAMO sys-
tem and the frailty level in a group of Italian
community-dwelling older adults. Specifically, the aims of
the study were: (1) to test differences in the MI levels of frail
and robust individuals, and (2) to compare the association of
the MI and a traditional physical measurement – the 400m
walk test - with frailty (total, physical, psychological and so-
cial frailty). We hypothesized that ADAMO system may be
useful to evaluate differences in the MI levels for frail and ro-
bust individuals. Moreover, as ADAMO system is worn dur-
ing everyday life activity and not in a laboratory setting, we
think that it may provide additional and more exhaustive in-
formation about older adults’ general health status.
Design and study population
The development and validation of ADAMO system is
part of the SPRINTT project (Sarcopenia & physical frailty
in older people: multi-component treatment strategies;
9th Call IMI 2013) aimed to validate and implement a
practical and clinical prevention of physical frailty and sar-
copenia and its complications [27, 28] (http://www.my-
sprintt.eu/en) [29]. However, this current paper does not
report direct data collected from SPRINTT project rather
is based on data recorded during an IMI-SPRINTT ancil-
lary Living Lab designed to test the acceptance of the
ADAMO carewatch for physical activity measurement.
Participants
Among the 35 persons contacted, 25 (71.4%) were en-
rolled in this study. Specifically, 5 (14.3%) did not meet
the study inclusion criteria and 5 (14.3%) did not agree
to participate. Recruitment of the study participants was
conducted in April 2017 in two sites (Turin and Rome)
and the data collection was performed in the period of
May/June 2017.
Participants satisfying all of the following criteria were
included: i) they were aged over 65 years; ii) they agreed to
test a connected device and to wear it continuously on
7-day duration; iii) they were able to come to the test
centre by themselves or accompanied by a family member;
iv) they were able to understand and answer the study
questionnaires; v) they could walk independently with or
without the use of assistive devices. Individuals with any
acute diseases (i.e., recent fractures or surgical operation)
and/or chronic diseases (i.e., dialysis, respiratory insuffi-
ciency, coronary disease, known myocardiopathies, severe
osteoarthritis) preventing the practical requirements for
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study participation or the administration of physical test
were excluded.
The study protocol was approved in the context of the
IMI (Innovative Medicine Initiative) in the grant agreement
No 115621 Sarcopenia and Physical fRailty IN older people:
multi-componenT Treatment strategies – SPRINTT – and
Amendment No 2, 22 May 2015. The study was performed
in accordance with the Declaration of Helsinki. All the par-
ticipants signed their written informed consent statement
in conformity with Italian law and the ethical code of the
American Psychological Association. No rewards or incen-
tives for participating were provided.
Procedure
At day one, participants came to the test centre to complete
preliminary procedures. Firstly, they have been informed
about the device and the protocol, they signed the informed
consent and they were screened in accordance with inclusion
criteria; secondly, they received the questionnaire to be au-
tonomously filled out at home and collected ADAMO care-
watch with detailed instructions about its activation; thirdly,
they performed the physical test (individually for each par-
ticipant and in the presence of an expert in exercise and
sport sciences). Completing the questionnaire took on an
average of 10min. Approximately, the same time-span was
required to perform the physical test. During the week, all
the participants received two phone calls: on day two to ver-
ify if there were any problems or doubts related to the use of
device, and on day six to remember them to fill out the
questionnaire and to make an appointment to pick the de-
vice up. The appointment was fixed starting from day eight
directly at participants’ home. On the occasion of the ap-
pointment, the operator asked about the encountered doubts
in completing the questionnaire and he/she checked for any
missing answer.
Measures
The mobility index (MI) referred throughout the 7-days
was obtained from ADAMO web service. The MI is a
parameter that explains the amount of physical activity
performed by the user, providing information about the
amount of time spent lying or sitting, standing still or
walking with different intensity. The MI is computed by
processing the acceleration pattern on the three axes
and taking into account the detected number of steps.
The MI provides the percentage of time spent through-
out 7-days in each of the following levels: (i) Very Low
Mobility: user is lying or sitting while resting (e.g., sleep-
ing, sitting); (ii) Low Mobility: user is lying or sitting per-
forming a slight activity (e.g., sitting having a meal,
playing cards, performing leisure activities in front of
television); (iii) Medium Mobility: user is still standing
or walking with a reduced intensity (e.g., cooking, iron-
ing); (iv) High Mobility: user is walking with a normal
intensity; and (v) Very High Mobility: user is walking
with a sustained pace. For each individual, the total
amount of these levels returns a score of 100%.
Walking ability was measured by the 400m walk test
[30]. Participants were instructed to walk 8 laps (50m per
lap) along a corridor inside the test centre building at their
usual pace without overexerting themselves. The total time
(s) for completing the test was collected using a manual
chronometer. If a participant referred of having chest pain
or dyspnea, the test was immediately stopped. The use of
assistive devices was allowed during the walk.
Frailty was evaluated using the part B of the Italian version
of the questionnaire Tilburg Frailty Indicator (TFI: [31, 32]).
The part B of the TFI is composed of 15 items related to
three domains (physical, psychological and social) of human
functioning [31]. The physical domain comprises eight items
about physical activity, unexplained weight loss, walking
problems, difficulty in balance, limited vision, hearing prob-
lems, strength in hands and physical tiredness. The psycho-
logical domain consists of four questions on cognition,
depression, anxiety and coping. The last three items belong
to the social domain and are related to living alone, social re-
lations and social support. The part B ranged from 0 (ab-
sence of frailty) to 15 (severe frailty), with a cut-off value
equal or higher than 5 that classifies frail from robust indi-
viduals [32].
Socio-demographic characteristics (i.e., age, gender,
marital status and level of education) and health condi-
tion status (i.e., usual use some drugs and the presence
of one or more chronic diseases) were self-reported.
Statistical analysis
Descriptive analyses were carried out for all the study
variables. Based on the data provided by ADAMO, the
following three continuous variables were obtained and
used for statistical analyses:
 Low Activity: percentage of time spent in Very Low
Mobility activity;
 Moderate Activity: sum of time percentages spent in
Low and Moderate Mobility activity;
 Vigorous Activity: sum of time percentages spent in
High and Very High Mobility activity.
In other words, the first two levels consisted of lying,
sitting or performing light activities activities, while the
other level consisted of walking activities at usual or sus-
tained pace. For each individual, the sum of Low, Mod-
erate and Vigorous Activities variables returns a score of
100%.
Firstly, controlling for age and gender, one-way analysis
of covariance (ANCOVA) was performed to investigate
differences in Low, Moderate, and Vigorous Activities be-
tween frail and robust individuals. Secondly, cluster
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analysis was carried out to detect participants with similar
levels of Low, Moderate and Vigorous Activities. Specific-
ally, the following two steps was performed: (i) hierarch-
ical cluster procedure using Ward’s method to individuate
the appropriate number of clusters by observing the den-
drogram; (ii) k-means clustering to partition individuals
into k homogenous groups. Using one-way analysis of
variance significant differences across the cluster centers
were identified. Lastly, to test the association of clusters
based on the MI levels and the 400m walk test with frailty
– total, physical, psychological, and social frailty – linear
regression analysis, controlling for participants’ age and
gender, was carried out. The Statistical Package for Social
Sciences, version 24.0 (SPSS Inc., Chicago, IL, USA) was
used for the analyses. The level of significance was set at
p < 0.05.
Results
Participants characteristics
Table 1 shows the characteristics of the study participants.
The mean age was 71 years (SD =6 years; range 65–89 years)
and most were women (60%), married (52%), and with a
level of education corresponding to secondary school (32%)
or to high school diploma (36%). A high number of partici-
pants referred to have one or more chronic diseases (60%)
and to consume drugs regularly (68%).
The means percentage of time spent in Low, Moderate
and Vigorous Activities were 51.4% (SD= 11.2%), 29.2% (SD
= 9.8%), and 19.4% (SD= 9.7%), respectively. On average,
participants completed the 400m walk test in 326 s (SD=
93 s; range 204–614 s). The mean TFI total score was 4.8
points (SD= 2.3 points; range 0–9 points). Overall, 14 (56%)
of 25 individuals were categorized as frail (TFI score ≥ 5
points).
Differences in MI levels between robust and frail
individuals
Significant differences between robust and frail individuals
were observed for Low Activity [F (1,21) = 40.3, p < 0.001],
Moderate Activity [F(1,21) = 8.6, p = 0.008], and Vigorous
Activity [F (1,21) = 5.1, p = 0.035]. See Table 2.
Relationship of the MI levels and the 400m walk test with
frailty
The hierarchical cluster analysis highlighted two clusters.
The cluster centers for Low Activity (p < 0.001) and
Moderate Activity (p = 0.001) were statistically different
from each other. On the contrary, the cluster centers for
Vigorous Activity did not show significant differences
between the two clusters. The first cluster (called “Good
MI”) consists of 12 individuals, characterized by low per-
centage of Low Activity associated with high level of
Moderate and Vigorous Activity. The second cluster
(called “Low MI”) includes 13 individuals, with a high
level of Low Activity and low level of Moderate and Vig-
orous Activity. See Table 3.
Linear regression analysis, controlling for age and gender,
showed that both clusters based on the MI and the 400m
walk test were associated with total and physical frailty. In
particular, both clusters based on MI and 400m walk test
Table 1 Characteristics of participants (N = 25)
Variables n (%) M (SD)
Age, years 71 (6)
Gender, number of women 15 (60)
BMI, kg/m2 29.4 (7.6)
Marital status
Married 13 (52)
Not married 3 (12)
Widowed 9 (36)
Level of education
Primary school, 5 years 5 (20)
Secondary school, 8 years 8 (32)
High school diploma, 13 years 9 (36)
University degree, 18 years 3 (12)
Chronic disease, number of Yes 15 (60)
Pharmacotherapy, number of Yes 17 (68)
MI provided by ADAMO, %
Low Activity 51.4 (11.2)
Moderate Activity 29.2 (9.8)
Vigorous Activity 19.4 (9.7)
400 m walk test, s 326 (93)
TFI, points 5 (5)
Physical TFI 2 (1)
Psychological TFI 1 (1)
Social TFI 1 (1)
Level of frailty a
Frail persons 14 (56)
Robust persons 11 (44)
Notes: a Individuals with a score equal or higher than 5 were classified frail. M,
mean; SD, Standard Deviation; BMI, Body Mass Index; TFI, Tilburg Frailty
Indicator, higher score corresponded to more severe frailty condition; MI,
Mobility index
Table 2 Differences of ADAMO mobility levels for frailty status
Group F
(1,21)
Effect
Size
p
Robust Frail
M (SD) M (SD)
Continuous Variables
Low Activity 58.8 (6.6) 42.0 (8.3) 40.3 0.657 <0.001
Moderate Activity 25.5 (7.6) 33.8 (10.6) 8.6 0.292 0.008
Vigorous Activity 15.7 (7.2) 24.2 (10.8) 5.1 0.195 0.035
Notes: M mean, SD Standard Deviation
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significantly predicted total (β= 0.571, p= 0.002 and β=
0.404, p= 0.043) and physical frailty (β= 0.381, p= 0.031 and
β= 0.668, p = 0.002). Clusters based on the MI were more
strongly associated with total frailty, while the 400m walk
test with physical frailty. These two models explained 35.2
and 35.7% of variance, respectively. Differently, only the clus-
ters based on the MI were associated with social frailty (β=
0.662, p < 0.001), explaining 48.3% of variance. Finally, no
statistical significant associations with psychological frailty re-
sulted. For more details see Table 4.
Discussion
The present study was designed to investigate the rela-
tionships between the MI levels provided by ADAMO sys-
tem and a mobility screening tool with frailty in a sample
of Italian community-dwelling older adults. To this end,
we compared the MI levels for frail and robust individuals
and investigated the association of the clusters based on
the MI levels and the 400m walk test with frailty (i.e.,
total, physical, psychological and social domains).
Our results showed that frail individuals reported different
MI levels compared with robust older adults depending on
intensity of daily activities. Indeed, frail individuals showed
higher percentage of time spent in Low Activity (i.e., lying or
sitting activities while resting) and lower percentage of time
spent in Low Moderate Activity (i.e., slight activity while
lying or sitting and standing or walking activity with reduced
intensity) and in Vigorous Activity (i.e., walking with normal
intensity or with a certain intensity). Interesting, data sug-
gested a moderate effect size in the difference between frail
and robust participants for Low Activity. In contrast, a small
effect was observed in the differences between these groups
for moderate and vigorous activity. Taken together, our re-
sults suggest that the differences between frail and robust
participants are more evident in Low Activity levels rather
than in Moderate or Vigorous Activities. Thus, we may
speculate that frail older adults reduce the intensity of the
execution of the activities of daily living and they spend more
time in a condition of rest in comparison with robust older
adults. Similar to our results, a study of Portegijs and col-
leagues [33] showed that mobility performances in different
life-space levels (e.g., bedroom, other rooms, outside home,
neighborhood, town, beyond) were negatively affected by
frailty status. Another study of Schwenk and colleagues [22]
demonstrated that parameters related to mobility discrimi-
nated frailty. Specifically, the daily percentage of mobility and
sitting time, the number of maximum continuous steps, the
walk bouts mean duration and the longest walking bout dur-
ation were all statistically different between frail and robust
older adults with better results for robust than frail people.
Therefore it is possible to assume that mobility restriction in
frail older adults might be due to the loss of reserve in one
or more frailty domains. Physical frailty may be considered a
geriatric syndrome characterized by progressive and general-
ized sarcopenia with an increased risk of physical disability,
poor quality of life and death [34]. For example, an impair-
ment in physical functioning (e.g., balance or gait dysfunc-
tions), an increased exhaustion perception, and/or the
onset of vision or hearing problems that are key indicators
of physical frailty can strongly impact on individual mobil-
ity [35]. As well indicators of psychological and social
frailty domains, such as depressive symptoms, anxiety per-
ception and/or loss of social relationships can affect mo-
bility in older adults [36, 37]. Special attention should be
drawn to the prevention of each component of frailty with,
for example, the implementation of multidomain inter-
ventions specific for the compromised domain.
Moreover we found that both the clusters based on
the MI levels and the 400 m walk test were associated
with total and physical frailty. Interestingly the clusters
based on the MI levels were strongly associated with
total frailty rather than the 400 m walk test. On the con-
trary, 400 m walk test was more strongly associated with
the physical frailty compared to the clusters based on
the MI levels. Differently, only clusters based on the MI
levels were associated with social frailty. These are ex-
pected findings, since the MI levels reflect the mobility
function in a continuous and non-intrusive way during
everyday life. Consequently data on the MI levels are
more informative and exhaustive than data provided by
a traditional physical measure of functioning, such as
the 400 m walk test, and probably they are able to
Table 3 Clusters based on ADAMO mobility index
ADAMO mobility
index
Clusters pa
1 – Good MI 2 – Low MI
Low Activity 42.2 59.9 <0.001
Moderate Activity 35.4 23.5 0.001
Vigorous Activity 22.4 16.6 0.142
Number of cases 12 13 –
Notes: a Results based on one-way ANOVA; MI, Mobility Index
Table 4 Relationship of ADAMO mobility index and the 400 m walk test with frailty
Components of
physical frailty
TFI Physical TFI Psychological TFI Social TFI
B SE β p B SE β p B SE β p B SE β p
Clusters based on MI 2.627 0.760 0.571 0.002 1.078 0.466 0.381 0.031 0.447 0.330 0.277 0.191 1.102 0.249 0.652 < 0.001
400m walk test 0.010 0.005 0.404 0.043 0.010 0.003 0.668 0.002 0.001 0.002 0.151 0.523 −0.002 0.002 −0.163 0.342
Notes: Analyses were adjusted for age and gender. TFI, Tilburg Frailty Indicator, higher score corresponded to severe frailty condition; SE, Standard Error; MI,
Mobility Index
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capture the complex relationship and interrelationships
among factors of different domains which can lead to
frailty. On the contrary, the 400 m walk test is a measure
limited to laboratory setting and it seems to be more in-
dicated to provide information just on physical health
status of individuals and during periodic assessment.
These results seems to be interesting and promising
since functional assessment is important to evaluate the
physical consequences of sarcopenia and malnutrition
that are often linked to frailty.
Some limitations should be underlined. First of all, the
small sample size did not allow us to generalize the results.
As a consequence, also the two clusters to discover mobility
profiles among individuals included a limited number of par-
ticipants. A larger sample size should be considered to im-
prove the causal interpretation of our results. Additionally,
based on the Mobility index provided by ADAMO system
we arbitrarily created three continuous variables: Low Activ-
ity (percentage of time spent in very low mobility activity),
Moderate Activity (sum of time percentages spent in low
and medium mobility activity) and High Activity (sum of
time percentages spent in high and very high mobility activ-
ity). Thus, caution is needed in interpreting these results.
Furthermore, the cross-sectional nature of the study did not
allow us to investigate the causal relationship between the
MI levels and frailty domains over time. Due to the limita-
tions of this study, future longitudinal studies are needed to
deepen the causal mechanism linking the MI levels provided
by ADAMO and frailty.
Conclusions
In conclusion, results from this study indicate that
ADAMO allows to measure mobility levels in a non-inva-
sive way providing wider information related to individual
general health condition, and specifically to frailty, in a
population of older adults. It is worth noting that ADAMO
is a time-saving tool and less stressful than traditional phys-
ical measures of functioning detected in a laboratory envir-
onment. Consequently, ADAMO may be an useful
telemonitoring tool for older adults.
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